KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE) EBT (2016 - 2025)

Historic EBT for Global Medical REIT (GMRE) over the last 10 years, with Q3 2025 value amounting to -$15.4 million.

  • Global Medical REIT's EBT fell 1779.47% to -$15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.4 million, marking a year-over-year decrease of 2003.63%. This contributed to the annual value of -$53.7 million for FY2024, which is 347.37% down from last year.
  • As of Q3 2025, Global Medical REIT's EBT stood at -$15.4 million, which was down 1779.47% from -$15.8 million recorded in Q2 2025.
  • Over the past 5 years, Global Medical REIT's EBT peaked at -$3.4 million during Q3 2021, and registered a low of -$15.9 million during Q4 2024.
  • Over the past 5 years, Global Medical REIT's median EBT value was -$12.0 million (recorded in 2024), while the average stood at -$10.8 million.
  • In the last 5 years, Global Medical REIT's EBT skyrocketed by 8098.32% in 2021 and then tumbled by 20177.58% in 2022.
  • Over the past 5 years, Global Medical REIT's EBT (Quarter) stood at -$4.9 million in 2021, then tumbled by 171.7% to -$13.4 million in 2022, then rose by 12.7% to -$11.7 million in 2023, then plummeted by 36.17% to -$15.9 million in 2024, then grew by 2.76% to -$15.4 million in 2025.
  • Its last three reported values are -$15.4 million in Q3 2025, -$15.8 million for Q2 2025, and -$12.3 million during Q1 2025.